Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma

BioTech Nation ... with Dr. Moira Gunn

Player FM - Internet Radio Done Right

تمت الإضافة منذ قبل three أعوام

المحتوى المقدم من BioTech Nation Team and Moira Gunn. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة BioTech Nation Team and Moira Gunn أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.

Lost Cultures: Living Legacies

1
Bermuda: The Crossroads of the Atlantic 51:57

منذ 14 يومًا51:57

التشغيل لاحقا

قوائم

إعجاب

احب

51:57

On the Season 2 debut of Lost Cultures: Living Legacies , we travel to Bermuda, an Atlantic island whose history spans centuries and continents. Once uninhabited, Bermuda became a vital stop in transatlantic trade, a maritime stronghold, and a cultural crossroads shaped by African, European, Caribbean, and Native American influences. Guests Dr. Kristy Warren and Dr. Edward Harris trace its transformation from an uninhabited island to a strategic outpost shaped by shipwrecks, colonization, the transatlantic slave trade, and the rise and fall of empires. Plus, former Director of Tourism Gary Phillips shares the story of the Gombey tradition, a vibrant performance art rooted in resistance, migration, and cultural fusion. Together, they reveal how Bermuda’s layered past continues to shape its people, culture, and identity today. You can also find us online at ⁠travelandleisure.com/lostcultures Learn more about your ad choices. Visit podcastchoices.com/adchoices…

منذ عام واحد 15:20

MP3•منزل الحلقة

This week I speak with Dr. Robert Ang from Vor Biopharma about their innovative approach to treating acute myeloid leukemia (AML). AML is a type of blood cancer that affects the bone marrow, leading to the overgrowth of cancerous cells. Dr. Ang explains that traditional treatments, such as chemotherapy and stem cell transplants, have limitations and risks. Dr. Ang emphasizes the potential of their treatment to revolutionize AML therapy and improve patient outcomes.

124 حلقات

#Science #Biology #Entrepreneur #Business #BioTech Nation Team #Moira Gunn #Biotech #Entrepreneurship #Bioentrepreneurship

BioTech Nation ... with Dr. Moira Gunn

Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma

BioTech Nation ... with Dr. Moira Gunn

published منذ عام واحد

MP3•منزل الحلقة

124 حلقات

#Science #Biology #Entrepreneur #Business #BioTech Nation Team #Moira Gunn #Biotech #Entrepreneurship #Bioentrepreneurship

كل الحلقات

BioTech Nation ... with Dr. Moira Gunn

1
PART II: A Regenerative Leap for Epilepsy… Dr. Cory Nicholas, Co-Founder and CEO, Neurona Therapeuitcs 27:03

منذ 14 يومًا27:03

27:03

This week on BioTech Nation, Dr. Cory Nicholas, CEO of Neurona Therapeutics, returns for part two. With early results now in from Neurona’s first clinical trial, patients with severe epilepsy are seeing dramatic improvements, including seizure reductions of over 90 percent, and even full remission in some cases. This one-time treatment delivers new brain cells that help calm seizure activity without the side effects of traditional medications or the risks of surgery.…

BioTech Nation ... with Dr. Moira Gunn

1
PART 1: A Regenerative Leap for Epilepsy…Dr. Cory Nicholas, Co-Founder and CEO, Neurona Therapeutics 24:27

منذ 21 يومًا24:27

24:27

This week on BioTech Nation, Dr. Cory Nicholas, Co-Founder and CEO of Neurona Therapeutics, discusses their groundbreaking success in treating drug-resistant epilepsy. With a single, targeted delivery of lab-grown brain cells, Neurona is offering not just symptom control but the possibility of long-term seizure relief. This is Part 1 of a two-part series exploring the future of regenerative medicine in neurology.…

BioTech Nation ... with Dr. Moira Gunn

1
Fighting Cancer, Easing Pain... Dr. Lorin Johnson, CSO, Glycyx Therapeutics 17:23

منذ 28 يومًا17:23

17:23

This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising their care. Dr. Lorin Johnson, CSO of Glycyx Therapeutics explains how a new once-daily pill could help patients manage pain without blocking their treatment.

BioTech Nation ... with Dr. Moira Gunn

1
Freezing Out Chronic Pain…Sameer Sabir CEO, Brixton Biosciences 14:21

منذ 5 weeks14:21

14:21

This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we treat joint pain without pills or repeated steroid injections.…

BioTech Nation ... with Dr. Moira Gunn

1
Beyond the One-Size-Fits-All Cure... Jeff Liter, Founder & CEO, Luminary Therapeutics 11:21

منذ 6 weeks11:21

11:21

This week on BioTech Nation, Luminary Therapeutics CEO Jeff Liter shares how his team is working to make advanced cell therapy easier to access and more affordable. Instead of using each patient’s own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.…

BioTech Nation ... with Dr. Moira Gunn

1
Beyond Pills and Shots... Sean Ainsworth, CEO, Immusoft 12:44

منذ 7 weeks12:44

12:44

This week on BioTech Nation, Sean Ainsworth, CEO of ImmuSoft, explains how modifying the body’s own B cells to produce therapeutic proteins could revolutionize drug delivery. From improving treatment for rare diseases like Hurler syndrome to potentially replacing injections for autoimmune and metabolic conditions, this new approach opens the door to long-term, patient-specific solutions.…

BioTech Nation ... with Dr. Moira Gunn

1
Breaking Barriers in Brain Cancer... Dr. Thomas Chen, Founder and CEO, NeOnc Technologies 24:39

منذ 8 weeks24:39

24:39

This week on BioTech Nation, Dr. Thomas Chen, Director of Neuro-Oncology at USC and Founder of NeOnc Technologies, shares treating glioblastoma by delivering a drug directly to the brain through nasal inhalation changes the drug delivery game, bypassing the blood-brain barrier. This technique is achieving results in clinical trials.…

BioTech Nation ... with Dr. Moira Gunn

1
The Future of Synthetic Biology... Dr. John Cumbers, Founder & CEO, SynBioBeta 18:53

منذ 9 weeks18:53

18:53

This week on BioTech Nation, I speak with Dr. John Cumbers, founder and CEO of SynBioBeta, the annual synthetic biology conference. We discuss how biology, AI, and technology are transforming industries, covering tracks on human health, planetary health, and hyperscale biology. SynBioBeta 2025 will take place in San Jose, CA, from May 5 to 8.…

BioTech Nation ... with Dr. Moira Gunn

1
Reimagining Bone Marrow Transplants... Kevin Caldwell, Co-Founder & CEO, Ossium Health 13:29

منذ 10 weeks13:29

13:29

This week on BioTech Nation, Ossium Health co-founder and CEO Kevin Caldwell shares how their breakthrough approach is changing bone marrow transplants. By cryobanking marrow from organ donors, Ossium is reducing wait times, improving access, and preparing for future emergencies. With support from BARDA and promising clinical trial results, this new system could help thousands more receive lifesaving transplants—right when they need them.…

BioTech Nation ... with Dr. Moira Gunn

1
When Your Immune System Attacks You... Prof. Dr. Niels Riedemann, Co-Founder & CEO, Inflarx 21:52

منذ 11 weeks21:52

21:52

This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to calm the immune system and why their breakthrough drug is getting attention from U.S. health agencies.…

BioTech Nation ... with Dr. Moira Gunn

1
Designing Healthcare for People... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 7:59

منذ 12 weeks7:59

7:59

This week on BioTech Nation, Dr. Daniel Kraft explores how smarter design can make healthcare easier, less stressful, and more effective. From hospitals built for patient comfort to medical apps that adapt to your needs, the way we experience healthcare is evolving. Learn how design thinking and empathy are shaping the future of medicine.…

BioTech Nation ... with Dr. Moira Gunn

1
Why One Drug Isn't Always Enough... Rich Daly, President & CEO, Catalyst Pharmaceuticals 19:01

منذ 13 weeks19:01

19:01

This week on BioTech Nation, Catalyst Pharmaceuticals CEO Rich Daly discusses the complexities of treating epilepsy and rare diseases. From the challenges of polypharmacy—where patients need multiple drugs to manage a single condition—to the hurdles of diagnosing and treating ultra-rare diseases.

BioTech Nation ... with Dr. Moira Gunn

1
A Second Chance for an ALS Drug... Dr. Ari Azhir, Founder & CEO, Neuvivo 17:47

منذ 14 weeks17:47

17:47

This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights and groundbreaking survival results, Neuvivo is giving hope to ALS patients and exploring its potential for other neurodegenerative diseases like Huntington’s and Alzheimer’s.…

BioTech Nation ... with Dr. Moira Gunn

1
The Mystery of "Dark" Proteins... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 9:29

منذ 15 weeks9:29

9:29

This week on BioTech Nation , Dr. Daniel Kraft explores the discovery of "dark" proteins, thousands of previously unknown proteins in the human body. Scientists believe these hidden proteins could be the key to detecting diseases earlier and developing new treatments.

BioTech Nation ... with Dr. Moira Gunn

1
9 Million Samples: A New Era of Medicine... Dr. Lincoln Nadauld, President & CEO, Culmination Bio 18:27

منذ 16 weeks18:27

18:27

This week on Biotech Nation, Dr. Lincoln Nadauld shares how Culmination Bio is using 9 million preserved tissue samples and decades of patient data to improve how we understand and treat diseases. From discovering patterns in cancer treatments to exploring breakthroughs in heart and autoimmune diseases, this unique approach is changing medicine.…

BioTech Nation ... with Dr. Moira Gunn

1
Mobility: The New Vital Sign….Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 13:50

منذ 17 weeks13:50

13:50

This week on Biotech Nation, Dr. Daniel Kraft discusses why mobility is emerging as a key indicator of health, just like heart rate or blood pressure. From wearable tech that tracks your gait to AI-powered exoskeletons and brain-computer interfaces, new innovations are transforming how we measure and maintain movement.…

BioTech Nation ... with Dr. Moira Gunn

1
Reprogramming the Future... Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology 25:51

منذ 18 weeks25:51

25:51

This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology share a bold new approach to fighting diseases of aging before they take hold. Instead of testing one drug at a time, their technology allows scientists to test hundreds of potential treatments at once, making drug discovery faster and more precise. This could change how we treat conditions like arthritis, heart failure, and fatty liver disease.…

BioTech Nation ... with Dr. Moira Gunn

1
One Drug, Many Diseases??? Dr. David Fajgenbaum, UPenn School of Medicine Professor and President of Every Cure 27:56

منذ 19 weeks27:56

27:56

Not just seeking treatment for every disease, but making sure the treatments we have already developed are being used in every possible way. I speak with Dr. David Fajgenbaum (Fay-gen-baum), a Professor of Translational Medicine and Human Genetics at the University of Pennsylvania School of Medicine, and President of Every Cure.…

BioTech Nation ... with Dr. Moira Gunn

1
A Daily Pill to Fight Autoimmune Diseases…Ben Zimmer, CEO of Priovant Therapeutics 21:53

منذ 20 weeks21:53

21:53

This week on Biotech Nation, Priovant Therapeutics CEO Ben Zimmer shares how their once-a-day pill could transform the treatment of severe autoimmune diseases like dermatomyositis and non-infectious uveitis. With phase 3 trials in progress, Priovant is offering hope to patients with few modern treatment options.…

BioTech Nation ... with Dr. Moira Gunn

1
Fighting Inflammation, and Alzheimer's??? Dr. David Bearss, President & CEO Halia Therapeutics 28:57

منذ 21 weeks28:57

28:57

In this week's episode of BioTech Nation, Dr. David Bearss, President and CEO of Halia Therapeutics, discusses inflammation and its reduction over a lifetime and in response to various incidents. He unveils the inflammasome, a recently discovered protein complex critical in regulating inflammatory responses and its potential in treating chronic diseases like myelodysplastic syndrome and Alzheimer's. Dr. Bearss shares insights into Halia's groundbreaking approach and his relentless pursuit of medical breakthroughs.…

BioTech Nation ... with Dr. Moira Gunn

1
Alcohol-Associated Hepatitis Treatment on the Horizon!!! Dr. Jim Brown, CEO of DURECT 14:52

منذ 22 weeks14:52

14:52

Dr. Jim Brown from DURECT talks about their clinical trials for Alcohol-Associated Hepatitis, a condition for which there is no approved treatment.

BioTech Nation ... with Dr. Moira Gunn

1
Data for Good!!!... Sir Rory Collins, Oxford Professor and Principal Investigator, UK Biobank 25:34

منذ 23 weeks25:34

25:34

Sir Rory Collins is a Professor of Medicine and Epidemiology at the University of Oxford and the Principal Investigator of the UK Biobank. With data from half a million people, it has served 30,000 scientists around the world, giving special support to young researchers and scientists in emergent countries.…

BioTech Nation ... with Dr. Moira Gunn

1
Building Technology and Solving Problems!!! Dave Pacitti, President & Head of the Americas, Siemens Healthineers 20:30

منذ 24 weeks20:30

20:30

When is a medical technology company more than a medical technology company? We’ll hear all about it when I speak with Dave Pacitti, the President and Head of the Americas at Siemens Healthineers. They’re out to solve problems bigger than the products they are known for.

BioTech Nation ... with Dr. Moira Gunn

1
Antidepressants Should Have Diagnostics??? Dr. Amit Etkin, Founder & CEO, Alto Neuroscience 25:57

منذ 25 weeks25:57

25:57

Major Depressive Disorder. Serious Depression. PTSD. Alto Neuroscience CEO, Dr. Amit Etkin talks about developing new and innovative drugs tied directly to each patient’s underlying biology. For every drug, there is a test...

BioTech Nation ... with Dr. Moira Gunn

1
Can AI Discover Drugs Better Than Humans?? Dr. Vimal Mehta, Co-Founder & CEO BioXcel 20:00

منذ 26 weeks20:00

20:00

Discover how their AI technology is revolutionizing drug discovery with Dr. Vimal Mehta, Co-Founder and CEO BioXcel and how this is leading to the approval of their first drug for agitation in bipolar I and II and schizophrenia, and paving the way for new treatments.

BioTech Nation ... with Dr. Moira Gunn

1
Food IS Medicine... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 10:37

منذ 27 weeks10:37

10:37

This week on Biotech Nation , Tech Nation Health Chief Correspondent, Dr. Daniel Kraft, talks about “food as medicine" and how eating real, minimally processed food can prevent chronic illnesses like diabetes and heart disease, starting with kids and school lunches. Programs like Eat Real and the federal Food is Medicine initiative are working to improve diets and health nationwide.…

BioTech Nation ... with Dr. Moira Gunn

1
Rewiring the Brain... Dr. Peter Vanderklish, Chief Scientific Officer, Spinogenix 25:28

منذ 28 weeks25:28

25:28

This week on BioTech Nation, Dr. Peter Vanderklish, Chief Scientific Officer at Spinogenix discusses their clinical trials focused on regenerating synapses to repair brain connections and offer hope for conditions like Alzheimer's, ALS, schizophrenia and depression. Phase 2 trials are underway. Check their website for patient recruitment information.…

BioTech Nation ... with Dr. Moira Gunn

1
Sepsis: First-Time-Ever Test... Dr. Rollie Carlson, CEO Immunexpress 12:42

منذ 29 weeks12:42

12:42

This week on BioTech Nation, Dr. Rollie Carlson, CEO of Immunexpress, talks about Sepsis—a deadly condition responsible for 1 in 5 deaths worldwide. Dr. Carlson talks about the FDA-cleared SeptiCyte test, a new tool that can quickly identify Sepsis within an hour, helping doctors treat it faster and avoid unnecessary antibiotics or even death.…

BioTech Nation ... with Dr. Moira Gunn

1
CRISPR Dilemma... Dr. Eben Kirksey, Anthropologist & Author, “The Mutant Project: Inside the Global Race to Genetically Modify Humans” 38:02

منذ 30 weeks38:02

38:02

This week on BioTech Nation, we talk with Dr. Eben Kirksey about the ethical issues behind CRISPR, the gene-editing tool that made headlines with the birth of the first “CRISPR babies” in China. Dr. Kirksey shares his experiences investigating this controversial experiment and highlights the deeper questions it raises. He stresses the importance of public dialogue, urging us to consider carefully who benefits from such powerful technologies as we shape the future of gene editing.…

BioTech Nation ... with Dr. Moira Gunn

1
AI & Better Health...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 12:02

منذ 31 weeks12:02

12:02

This week on BioTech Nation, Dr. Daniel Kraft talks about how AI can personalize health advice using data from devices like your smartwatch. He explains how this technology can help people make better choices to stay healthy and avoid major illnesses. Dr. Kraft envisions AI as a personal health coach, offering real-time tips and reminders tailored to each person's needs.…

BioTech Nation ... with Dr. Moira Gunn

1
A Smarter Path to Curing Diseases… Dr. Avak Kahvejian Founding CEO, Cellarity 19:44

منذ 32 weeks19:44

19:44

Dr. Avak Kahvejian, Founding CEO of Cellarity, explains their new approach to discovering drugs by using AI to look at how cells behave as a whole, rather than focusing on one part of the problem. This approach could lead to faster development of better treatments, such as a pill for sickle cell disease.…

BioTech Nation ... with Dr. Moira Gunn

1
Replacing Cells, Restoring Sight…Brian Culley, CEO, Lineage Cell Therapeutics 16:04

منذ 33 weeks16:04

16:04

Brian Culley, CEO of Lineage Cell Therapeutics, talks about a new approach to treating diseases called whole cell replacement therapy - which replaces damaged cells with new ones. Lineage is focusing this new therapy on dry age-related macular degeneration (AMD), a leading cause of blindness, through their collaboration with Genentech..…

BioTech Nation ... with Dr. Moira Gunn

1
Multimodal Health??? Dr. Daniel Kraft, Tech Nation Health, Chief Correspondent 9:17

منذ 34 weeks9:17

9:17

Dr. Daniel Kraft, Tech Nation Health Chief Correspondent introduces "multimodal medicine", combining data like proteomics, wearables, and imaging for early disease detection. He stresses the importance of both advanced diagnostics and listening to patients' stories for effective healthcare.

BioTech Nation ... with Dr. Moira Gunn

1
15 Billion Vaccines Doses: COVID & the Patent Dilemma... Dr. Antony Taubman, Former Director of the Intellectual Property Division at the World Trade Organization 23:14

منذ 35 weeks23:14

23:14

Dr. Antony Taubman, the former Director of the Intellectual Property Division at the World Trade Organization, discusses the challenges faced during the COVID-19 pandemic, including the rapid development and distribution of 15 billion doses of Covid vaccines, and how international intellectual property rules influenced these efforts.…

BioTech Nation ... with Dr. Moira Gunn

1
From Illness to Wellness - Can Science Tell Us How Healthy We Really Are (Part II)?? Dr. Leroy Hood and Dr. Nathan Price 25:03

منذ 36 weeks25:03

25:03

Part II - We continue our discussion with Dr. Leroy Hood and Dr. Nathan Price about the subject of their book "The Age of Scientific Wellness", delving into the role of artificial intelligence in healthcare and the ability to mine deep data to deliver hyper-personalized recommendations at a scale never before possible.…

BioTech Nation ... with Dr. Moira Gunn

1
From Illness to Wellness - Can Science Tell Us How Healthy We Really Are (Part I)?? Dr. Leroy Hood and Dr. Nathan Price 26:57

منذ 37 weeks26:57

26:57

Dr. Leroy Hood and Dr. Nathan Price delve into the subject of their book "The Age of Scientific Wellness", which highlights the advancements in science that enable the prediction and personalization of healthcare based on an individual's wellness level, and the potential advantages of early diagnosis and treatment of illnesses…

BioTech Nation ... with Dr. Moira Gunn

1
One Pill to Stop Many Cancers??? Dr. Michael Weickert, CEO, Pacylex Pharmaceuticals 16:54

منذ 38 weeks16:54

16:54

Dr. Michael Weickert, CEO of Pacylex Pharmaceuticals, about their once-daily pill in trials now for cancer treatment - it’s already showing early indicators of success in stopping cancer growth in not just one, but a number of cancers.

BioTech Nation ... with Dr. Moira Gunn

1
Engineering the Future of Vaccines... Dr. Robert Coleman, CEO, Codagenix 26:08

منذ 39 weeks26:08

26:08

Dr. Robert Coleman, CEO of Codagenix, discusses their innovative approach to virus engineering, which includes developing a nasally-delivered COVID-19 vaccine that targets multiple virus proteins for broader protection. Codagenix's "rational virus design" method creates genetically stable vaccines and therapeutics, reducing the risk of harmful mutations. Their work also extends to vaccines for other diseases and viral-based cancer treatments, with the potential to significantly advance global health.…

BioTech Nation ... with Dr. Moira Gunn

1
Did That Change To My Prescription Work??? -- Dr. Kal Patel, CEO, BrightInsight 35:13

منذ 40 weeks35:13

35:13

Continuous monitoring ... when we want it, when we don’t, should we share it? Or not. Or perhaps just part of it. Dr. Kal Patel, the Co-Founder and CEO of BrightInsight talks about this brave new frontier.

BioTech Nation ... with Dr. Moira Gunn

1
Can the Mapping of Human Biology Lead to Better Drugs? Dr. Chris Gibson, Co-Founder & CEO Recursion Pharmaceuticals 21:42

منذ 41 weeks21:42

21:42

Dr. Chris Gibson, the co-founder and CEO of Recursion Pharmaceuticals in Salt Lake City. We talk about their efforts to map ALL of human biology, and how this mapping will lead to better drugs.

BioTech Nation ... with Dr. Moira Gunn

1
One Company, Two Different Drugs - It's All About Glucose - Too Much and Too Little! Nevan Charles Elam, Founder & CEO, Rezolute 18:52

منذ 42 weeks18:52

18:52

Glucose is essential for life. And the insulin we produce is designed to leave just the right of amount in our bodies for healthy functioning. Thus, when we underproduce insulin - or we overproduce it - the results can be devastating. Nevan Charles Elam, Founder and CEO of Rezolute, tells us about their work to treat the “diabetic eye condition”, DME, and a pediatric condition called Congenital hyperinsulinism.…

BioTech Nation ... with Dr. Moira Gunn

1
A Vaccine for Breast Cancer??? Dr. Amit Kumar, President & CEO, Anixa Biosciences 25:39

منذ 43 weeks25:39

25:39

This week on BioTech Nation, Dr. Amit Kumar, President and CEO of Anixa Biosciences, talks about their work on a breast cancer vaccine which targets a protein thought only to be expressed during breastfeeding. Building on research by the Cleveland Clinic, Dr. Kumar describes ongoing human clinical trials and their potential for women with BRCA mutations.…

BioTech Nation ... with Dr. Moira Gunn

1
Are Your Genes Failing You??? Dr. Noah Davidsohn, Co-Founder & CSO Rejuvenate Bio 16:50

منذ 44 weeks16:50

16:50

This week on Biotech Nation, Dr. Noah Davidsohn, Co-Founder and Chief Scientific Officer of Rejuvenate Bio. The discussion centers around the regulation of protein expression and its implications for aging and health. Dr. Davidsohn explains how aging disrupts the balance of protein production, leading to various diseases. Rejuvenate Bio's gene therapies aim to restore this balance by targeting specific genes.…

BioTech Nation ... with Dr. Moira Gunn

1
Living Longer??? Dr. Peter Diamandis, XPrize Founder and Author, "Longevity" 25:33

منذ 45 weeks25:33

25:33

This week of BioTech Nation, Dr. Peter Diamandis about his new book, "Longevity: Your Practical Playbook on Sleep, Diet, Exercise, Mindset, Medications, and Not Dying from Something Stupid". We explore his lifelong interest in extending human health span and discuss practical steps for a healthier, longer life, including sleep, diet, exercise, and mindset. Dr. Diamandis introduces the "longevity escape velocity" concept and the HealthSpan XPRIZE, which aims to reverse aging's functional losses.…

BioTech Nation ... with Dr. Moira Gunn

1
Psychedelics... Prodrugs... What else? Dr. Sam Clark, CEO of Terran Biosciences 17:48

منذ 46 weeks17:48

17:48

This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's innovative, tech-inspired approach to rapidly develop affordable medications.…

BioTech Nation ... with Dr. Moira Gunn

1
Food as Medicine, A Personalized Prescription... Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 10:21

منذ 1 year10:21

10:21

Tech Nation Health, Chief Correspondent Dr. Daniel Kraft discusses the concept of "food as medicine." Dr. Kraft emphasizes the evolving understanding of nutrition and its profound impact on health, advocating for a shift towards personalized nutrition using cutting-edge technologies. From continuous glucose monitors to AI-powered apps and sensor toilets, we explore how these innovations enable individuals to measure and optimize their dietary choices.…

BioTech Nation ... with Dr. Moira Gunn

1
Repairing Minds, Naturally??? Mark Litton, President & CEO, Athira Pharma 22:38

منذ 1 year22:38

22:38

Alzheimer’s, Parkinson’s dementia, and other neurodegenerative diseases continue to be challenging, but now new science has led to a better understanding of the natural repair mechanisms in the brain. This, in turn, has generated new options for innovative treatments, and one such approach has entered late-stage human clinical trials. Dr. Mark Litton is the President and CEO of Athira Pharma.…

BioTech Nation ... with Dr. Moira Gunn

1
Combatting Blood Clots!!! Dr. Daniel Bloomfield, Chief Medical Officer, Anthos Therapeutics 14:31

منذ 1 year14:31

14:31

This week, Dr. Daniel Bloomfield from Anthos Therapeutics discusses the prevalence and dangers of blood clots, particularly in patients with cancer. Dr. Bloomfield explains the difference between normal and abnormal blood clotting, the risks associated with blood clots in arteries and veins, and the challenges in balancing clot prevention with the risk of bleeding.…

BioTech Nation ... with Dr. Moira Gunn

1
Heartburn, GERD, Cancer??? Dr. Lishan Aklog, CEO of Lucid Diagnostics 22:59

منذ 1 year22:59

22:59

Dr. Lishan Aklog from Lucid Diagnostics tells us about the path from GERD to, unfortunately, esophageal cancer, and about Lucid’s two-minute diagnostic test which can detect precancerous cells.

BioTech Nation ... with Dr. Moira Gunn

1
From Tummy Tucks to Drug Trials??? Dr. Eric Merle, Chief Business Innovation Officer, GenoSkin 14:23

منذ 1 year14:23

14:23

Dr. Eric Merle from GenoSkin talks about how they are transforming drug discovery using discarded human skin from surgeries like tummy tucks, revolutionizing the process and accelerating drug development timelines.

BioTech Nation ... with Dr. Moira Gunn

1
XPrize Foundation and $101 Million!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 11:14

منذ 1 year11:14

11:14

Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the newest XPrize worth an unprecedented $101 Million.

BioTech Nation ... with Dr. Moira Gunn

1
Wound Healing 2.0!!! Dr. Nik Sopko, Chief Scientific Officer at PolarityTE 15:19

منذ 1 year15:19

15:19

Dr. Nik Sopko, the Chief Scientific Officer of PolarityTE talks about their design for wound healing. Their first treatment candidate is diabetic foot ulcers.

BioTech Nation ... with Dr. Moira Gunn

1
Harnessing Natural Killer Cells!!! Dr. Eric Vivier, SVP & CSO of Innate Pharma 20:25

منذ 1 year20:25

20:25

Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.

BioTech Nation ... with Dr. Moira Gunn

1
Can Every Medicine Be a Pill??? Dr. Ray Stevens, CEO of ShouTi Pharma 24:24

منذ 1 year24:24

24:24

Dr. Ray Stevens, CEO of ShouTi Pharma, talks about their approach in turning IV drugs into pills. Current projects include Diabetes and obesity, and two Pulmonary and Cardiovascular disorders. And these are just their first candidates …

BioTech Nation ... with Dr. Moira Gunn

1
Gut-Brain Connections to Autism, Parkinson's, and More!!! Dr. Stewart Campbell, CEO Axial Therapeutics 25:38

منذ 1 year25:38

25:38

Dr. Stewart Campbell, CEO of Axial Therapeutics, about their groundbreaking work in Autism–related irritability in teenagers, in Parkinson’s, and in complementing the latest cancer treatments.

BioTech Nation ... with Dr. Moira Gunn

1
Ancient Viruses in our DNA??? Dr. Neil Shubin, Professor & Author University of Chicago 28:55

منذ 1 year28:55

28:55

On this week’s BioTech Nation University of Chicago professor Dr. Neil Shubin talks about his book “Some Assembly required … Decoding Four Billion Years of Life, from Ancient Fossils to DNA.” Ancient viruses in our DNA? And what about “jumping genes”?

BioTech Nation ... with Dr. Moira Gunn

1
Treating Diseases with Brain Implants??? Nicolas Vachicouras, CEO & Co-Founder Neurosoft Bioelectronics 15:44

منذ 1 year15:44

15:44

This week we visit the brain, and look at what a flexible brain implant might do – from sensing how your brain is working to actual treatment. Nicolas Vachicouras from Neurosoft Bioelectronics in Geneva, Switzerland talks about the target for their first treatment: severe tinnitus.

BioTech Nation ... with Dr. Moira Gunn

1
The Next Ozempic or Wegovy... But Without the Injection??? Dr. Steffen-Sebastian Bolz, CSO, Aphaia (ah-phi-ah) Pharma 24:36

منذ 2 years24:36

24:36

What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 2.

BioTech Nation ... with Dr. Moira Gunn

1
Who Could Forget About Dolly The Sheep??? Sir Ian Wilmut, Director, Scottish Centre for Regenerative Medicine 29:51

منذ 2 years29:51

29:51

We honor Sir Ian Wilmut, the Scottish embryologist who gained worldwide renown as the leader of the scientific research group that cloned the equally famous Dolly. With his recent passing, we air our 2007 BioTech Nation interview, when David Ewing Duncan and I spoke with Dr. Wilmut on the 10th anniversary of Dolly’s birth.…

BioTech Nation ... with Dr. Moira Gunn

1
Everybody Has a Thyroid... What Could Go Wrong??? Dr. Mark Sumeray, CMO of Amolyt Pharma 28:19

منذ 2 years28:19

28:19

Dr. Mark Sumeray from Amolyt Pharma talks about their innovative approach to treating hormonal conditions. We’ll talk about two – when your parathyroid has been injured or removed, often during thyroid surgery, and another – when the pituitary starts overproducing growth hormone.

BioTech Nation ... with Dr. Moira Gunn

1
A Dual Approach to Combatting Hepatitis... Dr. Marianne De Backer, CEO at Vir Biotechnology 19:52

منذ 47 weeks19:52

19:52

This week on Biotech Nation, Dr. Marianne De Backer, CEO of Vir Biotechnology talks about their Phase 2 clinical trials targeting hepatitis B and D co-infections. Vir's approach uses two drugs: tobevibart (an antibody) and elebsiran (an siRNA). These drugs prevent the virus from entering liver cells and stop it from replicating. Preliminary results are promising, showing a significant reduction in viral RNA and normalization of liver enzyme levels. Dr. De Backer also highlights Vir's efforts in other infectious diseases and future plans.…

BioTech Nation ... with Dr. Moira Gunn

1
Solving Genetic Diseases??? Dr. Neil Kumar, Founder & CEO, BridgeBio Pharma 23:18

منذ 48 weeks23:18

23:18

This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of multiple specialized companies under a centralized infrastructure to efficiently tackle various genetic diseases. This model allows for focused expertise on individual conditions while sharing common resources. Dr. Kumar highlights the company's commitment to using diverse therapeutic modalities, such as small molecules and gene therapies, to develop treatments that address the underlying causes of these diseases.…

BioTech Nation ... with Dr. Moira Gunn

منذ 1 year15:20

15:20

BioTech Nation ... with Dr. Moira Gunn

1
It’s All About Cancer, and Covid??? Dr. Andrew Allen, President, CEO, & Co-Founder Gritstone Bio 43:28

منذ 2 years43:28

43:28

This week on BioTech Nation, Andrew Allen, President, CEO and Co-Founder of Gritstone Bio – a full spectrum look at how cancer starts and cancer treatments have developed … and what next-generation treatment means today with Gritstone’s work in colorectal cancer. And wait for it … the next generation of Covid vaccines.…

BioTech Nation ... with Dr. Moira Gunn

1
Is Medical School Curriculum Outdated??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 11:43

منذ 2 years11:43

11:43

Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about how Medical Schools decide what to teach. You might be surprised that it’s based on the Flexner Report … written in … 1910. Is it time for a do-over? And what might that be?

BioTech Nation ... with Dr. Moira Gunn

1
Your Digital Twin May Already Exist!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 6:50

منذ 2 years6:50

6:50

Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about your Digital Twin … your Digital Twin … yes, you have one.

BioTech Nation ... with Dr. Moira Gunn

1
A New Approach To Treating Diabetes... Dr. Anthony Japour, President & CEO, iTolerance 12:40

منذ 2 years12:40

12:40

Dr. Anthony Japour, President and CEO from iTolerance in Miami, Florida tells us about implanting insulin-producing cells in your pancreas – it’s been tried before, but they have a new approach which just might work.

BioTech Nation ... with Dr. Moira Gunn

1
What's New in Digital Health!!! Dr. Daniel Kraft, Tech Nation Health Chief Correspondent 11:17

منذ 2 years11:17

11:17

Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the explosion of digital health.

BioTech Nation ... with Dr. Moira Gunn

1
Google's First Radio Interview Ever!!! Larry Page & Sergey Brin, Co-Founders, Google 28:15

منذ 2 years28:15

28:15

It’s the 25th anniversary of the founding of Google … and 23 years ago, Google founders - Larry Page and Sergey Brin – came to the Tech Nation studios to do their very first radio interview. There’s lots to learn there, including they believed what humans demanded of search, and why they did what they did.…

BioTech Nation ... with Dr. Moira Gunn

1
Old Dog, New Tricks ??? ... Dr. Robert Ladner, CEO & Founder, CV6 Therapeutics 21:11

منذ 2 years21:11

21:11

Dr. Robert Ladner, the Founder of CV6 Therapeutics in Belfast, Northern Ireland, tells us about their work to make a cornerstone cancer chemotherapy, even more effective. First trials are in colorectal and gastrointestinal cancers...

BioTech Nation ... with Dr. Moira Gunn

1
Can Good Viruses Kill Deadly Infections??? Tom Ireland, Science Journalist & Author 28:57

منذ 2 years28:57

28:57

Science journalist Tom Ireland tells us about a burgeoning field of science, which is changing the fight to successfully treat antibiotic infections. His book is “The Good Virus: The Amazing Story and Forgotten Promise of the Phage”.

BioTech Nation ... with Dr. Moira Gunn

1
Osteoarthritis... Mostly in the Knee, But Pick a Joint!!! Dr. Diem Nguyen, CEO of Xalud Therapeutics 18:39

منذ 2 years18:39

18:39

Osteoarthritis – mostly in the knee, but pick a joint. Dr. Diem (Zem) Nguyen (N’Win) is the CEO of Xalud (Za-lood) Therapeutics. We’ll talk about their work to reduce the inflammation that drives pain. It’s now in human clinical trials.

BioTech Nation ... with Dr. Moira Gunn

1
Why Do AI One Way, When You Can Do it 25??? Dr. Ben Thomas and Dermot Tierney, CEO & CCO, Amply Discovery 21:49

منذ 2 years21:49

21:49

Why use one AI approach when you can use 25? CEO Dr. Ben Thomas and Chief Commercial Officer Dermot Tierney from Amply Discovery talks about how their novel approach to AI in drug discovery.

BioTech Nation ... with Dr. Moira Gunn

1
Acute Cannabis Intoxication... Is There An Antidote??? Dr. Ken Cundy, CSO at Anebulo Pharmaceuticals 18:53

منذ 2 years18:53

18:53

Modern cannabis products, with higher potency than those from the past, can lead to acute cannabis intoxication. Anebulo Pharmaceuticals, led by Chief Scientific Officer Dr. Ken Cundy, is working on an antidote that counteracts the negative effects of THC overdose, potentially benefiting both adults and children.…

BioTech Nation ... with Dr. Moira Gunn

1
Gliobastoma + New View on Clinical Trials... Dr. Fahar Merchant, President & CEO Medicenna Therapeutics 22:38

منذ 2 years22:38

22:38

Glioblastoma is the most aggressive form of brain cancer, and progress in treating Glioblastoma has been elusive. Now, Toronto-based Medicenna has completed a successful Phase 2 with its innovative drug, and is now deep into planning the Phase 3 Trial. Also of interest, the FDA agreed to an unprecedented approach in Phase 2, which not only yields better science, but reduces the cost of the clinical trials themselves. To be sure, this approach will be carried forward into Phase 3. Dr. Fahar Merchant is the President & CEO of Medicenna Therapeutics.…

BioTech Nation ... with Dr. Moira Gunn

1
Innovation in Head & Neck Cancers!!! Dr. Mark Newman, CSO, GeoVax 14:40

منذ 2 years14:40

14:40

In this week's BioTech Nation, we discuss Geovax, a company working on a novel approach to treat head and neck cancers, which are often difficult to treat after standard options have been exhausted. Geovax is developing A2 component therapy, using an enzyme delivered directly to the tumor by a needle injection, followed by an infusion of an inactive form of a chemotherapeutic drug, which becomes toxic to the tumors when processed by the enzyme. The treatment aims to localize the effects, reduce side effects, and potentially activate the immune system to target other tumor cells in the body. Phase two trials are underway, with promising results so far.…

BioTech Nation ... with Dr. Moira Gunn

1
We Still Can't Ignore Long Covid... Dr. Jeffrey Cleland, CEO Ashvattha Therapeutics 9:54

منذ 2 years9:54

9:54

In this week's episode of Biotech Nation, Dr. Jeffrey Cleland, the President and CEO of Ashvattha Therapeutics, discusses their drug development efforts to address long COVID. They discuss the definition of long COVID by the World Health Organization, the prevalence of the condition, and the chronic inflammation that occurs in the body, including the brain. Dr. Cleland explains how their nanomedicine approach aims to selectively target and turn off reactive inflammatory cells, potentially offering a treatment for long haul COVID and other diseases.…

BioTech Nation ... with Dr. Moira Gunn

1
Can The Time Needed for CAR-T be shortened? EXUMA Says Yes!!! Dr. Gregory Frost, CEO, EXUMA Biotech 10:21

منذ 2 years10:21

10:21

In this week's episode of Biotech Nation, Dr. Greg Frost, CEO of Exuma Biotech, discusses their innovative approaches to cancer treatment. They are working on a method to shorten the time and eliminate hospital stays for CAR-T therapy, while also developing a new technology called G-car that combines T cells and NK cells to create a more gentle and effective cancer therapy.…

مرحبًا بك في مشغل أف ام!

يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.

الاستماع إلى +500 موضوع

مشابه لـBioTech Nation ... with Dr. Moira Gunn

TurboTax Deluxe 2024 Tax Software, Federal & State Tax Return [PC/MAC Download]

TERRO Ant Killer Bait Stations T300B - Liquid Bait to Eliminate Ants - 12 Count Stations for Effective Indoor Ant Control

Mighty Patch™ Original patch from Hero Cosmetics - Hydrocolloid Acne Pimple Patch for Covering Zits and Blemishes in Face and Skin, Vegan-friendly and Not Tested on Animals (36 Count)

المدونة الصوتية تستحق الاستماع

BioTech Nation ... with Dr. Moira Gunn « » Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma

Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma

المدونة الصوتية تستحق الاستماع

مرحبًا بك في مشغل أف ام!

The Let Them Theory: A Life-Changing Tool That Millions of People Can't Stop Talking About

The Let Them Theory: A Life-Changing Tool That Millions of People Can't Stop Talking About

Nespresso Capsules Vertuo, Variety Pack, Medium and Dark Roast Coffee, 30 Count Coffee Pods, Brews 7.8 oz.

The Let Them Theory: A Life-Changing Tool That Millions of People Can't Stop Talking About

مشابه لـBioTech Nation ... with Dr. Moira Gunn

BioTech Nation ... with Dr. Moira Gunn « »
Redefining Acute Myeloid Leukemia (AML) Treatment!!! Dr. Robert Ang, President & CEO of Vor Biopharma